FDA approves Moderna's mRNA flu vaccine after initial pushback

Categories: healthscience

Quick Summary

The US Food and Drug Administration (FDA) has approved Moderna's mRNA flu vaccine, marking the first time an mRNA flu vaccine has been approved in the US. The vaccine is approved for use in individuals 18 years and older. Moderna plans to make the vaccine available for the upcoming flu season, which could potentially provide better protection against the flu compared to traditional flu vaccines.

Key Points

  • The FDA has approved Moderna's mRNA flu vaccine
  • This is the first mRNA flu vaccine to be approved in the US
  • The vaccine is approved for individuals 18 years and older
  • Moderna plans to make the vaccine available for the upcoming flu season
View Original Article
This summary is AI generated and may be inaccurate